FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199796668> ?p ?o ?g. }

• W3199796668 endingPage "2273" @default.
• W3199796668 startingPage "2262" @default.
• W3199796668 abstract "Abstract Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that utilizes antibody–IRDye700DX (IR700) conjugates. The clinical use of NIR-PIT has recently been approved in Japan for patients with inoperable head and neck cancer targeting human epidermal growth factor receptor (hEGFR). Previously, cytotoxic T-lymphocyte antigen 4 (CTLA4)–targeted NIR-PIT has been shown to strongly inhibit tumor progression and prolonged survival was seen in different tumor models due to enhanced T-cell–mediated antitumor immunity. In this study, combined NIR-PIT targeting CTLA4 expressing cells and cancer cells was investigated in four tumor models including a newly established hEGFR-expressing murine oropharyngeal cancer cell (mEERL-hEGFR). While single molecule–targeted therapy (NIR-PIT targeting hEGFR or CTLA4) did not inhibit tumor progression in poorly immunogenic mEERL-hEGFR tumor, dual (CTLA4/hEGFR)-targeted NIR-PIT significantly suppressed tumor growth and prolonged survival resulting in a 38% complete response rate. After the dual-targeted NIR-PIT, depletion of CTLA4 expressing cells, which were mainly regulatory T cells (Tregs), and an increase in the CD8+/Treg ratio in the tumor bed were observed, suggesting enhanced host antitumor immunity. Furthermore, dual-targeted NIR-PIT showed antitumor immunity in distant untreated tumors of the same type. Thus, simultaneous cancer cell–targeted NIR-PIT and CTLA4-targeted NIR-PIT is a promising new cancer therapy strategy, especially in poorly immunogenic tumors where NIR-PIT monotherapy is suboptimal." @default.
• W3199796668 created "2021-09-27" @default.
• W3199796668 creator A5004666913 @default.
• W3199796668 creator A5011843655 @default.
• W3199796668 creator A5032348337 @default.
• W3199796668 creator A5037488751 @default.
• W3199796668 creator A5042339519 @default.
• W3199796668 creator A5051297807 @default.
• W3199796668 creator A5082080836 @default.
• W3199796668 creator A5085355727 @default.
• W3199796668 creator A5089871257 @default.
• W3199796668 creator A5090173640 @default.
• W3199796668 date "2021-09-13" @default.
• W3199796668 modified "2023-10-17" @default.
• W3199796668 title "Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models" @default.
• W3199796668 cites W1518520618 @default.
• W3199796668 cites W1872608557 @default.
• W3199796668 cites W1972684058 @default.
• W3199796668 cites W1983692618 @default.
• W3199796668 cites W1991133653 @default.
• W3199796668 cites W1996217426 @default.
• W3199796668 cites W2017045575 @default.
• W3199796668 cites W2024832944 @default.
• W3199796668 cites W2069154921 @default.
• W3199796668 cites W2080644862 @default.
• W3199796668 cites W2097995306 @default.
• W3199796668 cites W2102339709 @default.
• W3199796668 cites W2103837565 @default.
• W3199796668 cites W2109856804 @default.
• W3199796668 cites W2112121482 @default.
• W3199796668 cites W2118341617 @default.
• W3199796668 cites W2123363005 @default.
• W3199796668 cites W2131661704 @default.
• W3199796668 cites W2131874142 @default.
• W3199796668 cites W2309182806 @default.
• W3199796668 cites W2365243214 @default.
• W3199796668 cites W2513056697 @default.
• W3199796668 cites W2518249323 @default.
• W3199796668 cites W2529373149 @default.
• W3199796668 cites W2534742154 @default.
• W3199796668 cites W2565382901 @default.
• W3199796668 cites W2572174216 @default.
• W3199796668 cites W2578528809 @default.
• W3199796668 cites W2606604537 @default.
• W3199796668 cites W2622275391 @default.
• W3199796668 cites W2624126191 @default.
• W3199796668 cites W2752227448 @default.
• W3199796668 cites W2754623626 @default.
• W3199796668 cites W2765170013 @default.
• W3199796668 cites W2767336741 @default.
• W3199796668 cites W2767343890 @default.
• W3199796668 cites W2768429453 @default.
• W3199796668 cites W2769767397 @default.
• W3199796668 cites W2781709257 @default.
• W3199796668 cites W2791192045 @default.
• W3199796668 cites W2806145459 @default.
• W3199796668 cites W2900131693 @default.
• W3199796668 cites W2913388824 @default.
• W3199796668 cites W2964086043 @default.
• W3199796668 cites W2972756137 @default.
• W3199796668 cites W2976352116 @default.
• W3199796668 cites W2998887723 @default.
• W3199796668 cites W3044220074 @default.
• W3199796668 cites W3082951021 @default.
• W3199796668 cites W3085217623 @default.
• W3199796668 cites W3110845970 @default.
• W3199796668 cites W3128757325 @default.
• W3199796668 cites W3133091495 @default.
• W3199796668 cites W3158479474 @default.
• W3199796668 cites W3160103920 @default.
• W3199796668 cites W3164133397 @default.
• W3199796668 doi "https://doi.org/10.1158/1535-7163.mct-21-0470" @default.
• W3199796668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34518299" @default.
• W3199796668 hasPublicationYear "2021" @default.
• W3199796668 type Work @default.
• W3199796668 sameAs 3199796668 @default.
• W3199796668 citedByCount "19" @default.
• W3199796668 countsByYear W31997966682022 @default.
• W3199796668 countsByYear W31997966682023 @default.
• W3199796668 crossrefType "journal-article" @default.
• W3199796668 hasAuthorship W3199796668A5004666913 @default.
• W3199796668 hasAuthorship W3199796668A5011843655 @default.
• W3199796668 hasAuthorship W3199796668A5032348337 @default.
• W3199796668 hasAuthorship W3199796668A5037488751 @default.
• W3199796668 hasAuthorship W3199796668A5042339519 @default.
• W3199796668 hasAuthorship W3199796668A5051297807 @default.
• W3199796668 hasAuthorship W3199796668A5082080836 @default.
• W3199796668 hasAuthorship W3199796668A5085355727 @default.
• W3199796668 hasAuthorship W3199796668A5089871257 @default.
• W3199796668 hasAuthorship W3199796668A5090173640 @default.
• W3199796668 hasBestOaLocation W31997966681 @default.
• W3199796668 hasConcept C121608353 @default.
• W3199796668 hasConcept C126322002 @default.
• W3199796668 hasConcept C147483822 @default.
• W3199796668 hasConcept C154317977 @default.
• W3199796668 hasConcept C167672396 @default.
• W3199796668 hasConcept C202751555 @default.
• W3199796668 hasConcept C203014093 @default.

• next